Large-for-gestational-age infant and infants of diabetic mothers — viva

Stem

The examiner hands you the antenatal summary of a 39-week infant: birthweight 4350 g (above the 97th centile), maternal gestational diabetes managed with metformin with a high third-trimester HbA1c, a plump plethoric neonate with disproportionate shoulder adiposity, now jittery in the nursery. [4]

Examiner: What is your opening approach to this infant? [4]

Strong answer: I would first classify this as an infant of a diabetic mother with a hyperinsulinaemic macrosomic phenotype, because the mother has poorly controlled gestational diabetes and the infant has the disproportionate truncal adiposity and visceromegaly of hyperinsulinaemia rather than constitutional overgrowth. I would plot the weight, length and head circumference on a gestation- and sex-specific chart, then pre-empt the complications from the first feed — warmth, early and frequent feeding, scheduled pre-feed glucose monitoring, and the hypoglycaemia ladder. I would also screen for polycythaemia, respiratory distress, cardiomyopathy and birth injury. [1] [2]

Branch 1 — Classification

Examiner: How do you distinguish LGA, macrosomia and IDM? [5]

Strong answer: LGA is a centile word — birthweight above the 90th centile for gestational age and sex. Macrosomia is an absolute weight word — commonly above 4000 g, with above 4500 g considered severe. IDM is a maternal-history word — any infant whose mother had pregestational or gestational diabetes. They overlap because poorly controlled diabetes drives fetal hyperinsulinaemia and overgrowth, but most LGA infants are constitutionally large, and a well-controlled IDM may be normally grown. [5]

Examiner probe: What physical features point to a hyperinsulinaemic rather than a constitutional cause? [4]

Strong answer: Disproportionate truncal and shoulder adiposity, visceromegaly (a palpable liver from glycogen storage), and plethora, set against a known diabetic pregnancy, point to hyperinsulinaemia. A constitutionally large infant is simply a proportionate, muscular, well-grown version of a normal baby without that body habitus. [4]

Branch 2 — Pathophysiology and prognosis

Examiner: Explain the Pedersen hypothesis in one chain. [3]

Strong answer: Glucose crosses the placenta freely but maternal insulin does not, so maternal hyperglycaemia drives fetal pancreatic hyperinsulinaemia. Insulin is the dominant fetal growth hormone, producing macrosomia. After cord clamping the maternal glucose supply stops abruptly but insulin persists, driving blood glucose down — the mechanism of IDM hypoglycaemia. The same hyperinsulinaemia drives polycythaemia (via relative hypoxia and erythropoietin), delayed surfactant maturation (RDS even at term), and myocardial hypertrophy (cardiomyopathy). [3]

Examiner probe: Why does scheduled glucose monitoring matter for prognosis? [1]

Strong answer: Severe or recurrent neonatal hypoglycaemia is associated with adverse neurodevelopment at 2 and 4.5 years. Because the IDM's insulin peaks over the first hours, a single normal reading does not clear the infant — repeated pre-feed checks detect the nadir and prompt treatment, which is why pre-empting hypoglycaemia from the first feed is evidence-based, not over-cautious. [1]

Branch 3 — A trap

Examiner: The registrar wants to start dobutamine for an IDM in heart failure with echocardiographic septal hypertrophy. How do you respond? [4]

Strong answer: I would not. Hypertrophic cardiomyopathy of the IDM causes dynamic left ventricular outflow obstruction, and an inotrope that increases contractility worsens that obstruction. Management is supportive — fluid restriction, treat the underlying disturbance, and time — and the hypertrophy usually regresses over weeks to months. I would involve cardiology. [4]